Online now: Agonistic anti-CD40 antibody treatment converts resident regulatory T cells into activated type 1 effectors within the tumor microenvironment https://www.cell.com/immunity/fulltext/S1074-7613(26)00122-6?rss=yes&utm_source=dlvr.it&utm_medium=mastodon
| Website | http://cell.com/immunity |
| http://twitter.com/ImmunityCP |









